Arthropathic psoriasis

L12_PSORI_ARTHRO

psoriatic arthritis: Joint inflammation associated with psoriasis.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L40.5+, L40.5+M07.0, L40.5+M07.1, L40.5+M07.2, L40.5+M07.3, L40.5+M09.0 Hospital discharge: ICD-9 — 6960A Hospital discharge: ICD-8 — 69600 Cause of death: ICD-10 — L40.5+, L40.5+M07.0, L40.5+M07.1, L40.5+M07.2, L40.5+M07.3, L40.5+M09.0 Cause of death: ICD-9 — 6960A Cause of death: ICD-8 — 69600 2 out of 7 registries used, show all original rules.	4647
4. Check minimum number of events None	4647
5. Include endpoints None	4647
6. Filter based on genotype QC (FinnGen only)	4647

Control definitions (FinnGen only)

Control exclude: L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF9

NAME	L12_PSORI_ARTHRO
CONTROL_EXCLUDE	L12_PAPULOSQUAMOUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L405
HD_ICD_9	6960A
HD_ICD_8	69600
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L405
COD_ICD_9	6960A
COD_ICD_8	69600
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Arthropathic psoriasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Psoriatic arthropathies, strict definition

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4647	2557	2090
Unadjusted period prevalence (%)	0.89	0.87	0.92
Median age at first event (years)	50.92	50.89	50.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4202: Matched controls
42020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S91

ICPC

Psoriasis

144.3

323.0

369

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

7.0

323.0

1032

1869

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

1882.1

323.0

333

D07AC01

ATC

betamethasone; topical

6.5

323.0

2677

8985

D05BB02

ATC

acitretin; oral

67.7

323.0

639

111

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

+∞

323.0

377

L04AB04

ATC

adalimumab; parenteral

33.3

323.0

683

243

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

31.1

323.0

1300

597

E0000UV

ATC

4.9

323.0

2625

10629

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

30.4

323.0

976

414

E000001

ATC

5.2

323.0

1667

4695

L40.9

ICD-10 Finland

Psoriasis, unspecified

113.9

323.0

439

L40

ICD-10 Finland

Psoriasis

54.5

323.0

492

102

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

51.8

323.0

3137

2260

A07EC01

ATC

sulfasalazine; oral, rectal

21.5

323.0

1970

1658

L40.5

ICD-10 Finland

Arthropathic psoriasis

3943.8

323.0

2591

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

14251.1

323.0

3523

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

65.7

323.0

3073

1670

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

21.2

323.0

1665

1263

L40.0

ICD-10 Finland

Psoriasis vulgaris

382.9

323.0

1896

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

19.0

323.0

1585

1295

M07.3

ICD-10 Finland

Other psoriatic arthropathies

1125.7

323.0

1473

L04AA13

ATC

leflunomide; oral

25.6

323.0

800

382

L88

ICPC

Rheumatoid/seropositive arthritis

14.9

323.0

766

621

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

32.0

323.0

956

383

D07XC01

ATC

betamethasone, combinations; topical

18.7

323.0

2141

2206

D05AX02

ATC

calcipotriol; topical

77.5

323.0

1582

324

L04AB01

ATC

etanercept; parenteral

29.1

323.0

466

179

H02AB06

ATC

prednisolone; systemic

3.9

323.0

2745

13654

D05AX52

ATC

calcipotriol, combinations; topical

72.7

323.0

2044

539

D07AC13

ATC

mometasone; topical

4.0

323.0

1987

7679

D07AD01

ATC

clobetasol; topical

7.9

323.0

1645

3170

D05AX03

ATC

calcitriol; topical

105.2

323.0

541

M13.9

ICD-10 Finland

Arthritis, unspecified

6.7

288.2

808

1438

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

283.6

269

L04AC10

ATC

secukinumab; parenteral

153.3

271.5

286

L40.8

ICD-10 Finland

Other psoriasis

161.4

259.2

272

D07AB02

ATC

hydrocortisone butyrate; topical

3.4

258.0

1744

7329

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

1270.9

248.3

240

E000003

ATC

8.5

222.7

518

683

E000002

ATC

4.6

221.5

880

2295

P01BA02

ATC

hydroxychloroquine; oral

5.1

209.9

743

1708

L04AA32

ATC

apremilast; oral

1978.8

206.8

199

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

1935.3

202.6

195

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

+∞

194.3

185

L04AC13

ATC

ixekizumab; parenteral

+∞

189.0

180

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.8

187.8

700

1686

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

184.2

2169

12216

D05AA

ATC

Tars

51.0

179.9

218

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

+∞

176.3

168

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.8

165.9

1333

5892

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

27.1

165.2

231

M25.5

ICD-10 Finland

Pain in joint

2.6

160.3

1572

7797

NH3EA

NOMESCO Finland

Feet X-ray examination with load

10.8

158.5

318

317

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.6

155.0

491

975

L04AD01

ATC

ciclosporin; systemic

11.2

154.4

303

289

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

10.7

152.4

306

305

M01AH05

ATC

etoricoxib; oral

2.4

149.9

2860

19785

D02AE01

ATC

carbamide; topical

4.9

147.9

529

1201

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

9.5

147.3

317

359

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

144.6

138

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

30.1

140.0

190

L04AB06

ATC

golimumab; parenteral

23.6

139.7

203

D07AB08

ATC

desonide; topical

3.7

138.6

680

2074

L04AC05

ATC

ustekinumab; parenteral

65.6

136.1

158

134

Kela drug reimbursment

General erythroderma

206.8

135.6

140

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

+∞

134.1

128

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

13.3

124.5

224

177

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

124.0

1504

8079

L40.4

ICD-10 Finland

Guttate psoriasis

122.9

121.8

131

L04AA01

ATC

[U] ciclosporin; systemic

11.6

119.7

230

209

M01AC06

ATC

meloxicam; systemic, rectal

2.2

117.9

1799

10698

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

7.2

117.0

299

443

TNG10

NOMESCO Finland

Puncture of knee

15.2

114.9

195

134

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

113.9

565

1720

TQW80

NOMESCO Finland

Local dermatologic skincare

8.4

113.6

261

328

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

9.1

110.2

241

279

M01AH01

ATC

celecoxib; oral (coxibs)

2.6

109.5

989

4498

299

Kela drug reimbursment

+∞

107.8

103

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.9

104.7

251

337

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

7.6

103.6

254

353

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

10.4

103.2

209

210

H02AB07

ATC

prednisone; oral

2.7

100.4

781

3238

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

13.5

96.7

172

132

M01CB03

ATC

auranofin; oral

18.2

95.6

151

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.5

93.2

486

1527

E000006

ATC

3.6

91.8

452

1355

L20

ICPC

Joint symptom/complaint NOS

5.3

88.3

285

568

D05AX05

ATC

tazarotene; topical

183.8

86.5

L04AB05

ATC

certolizumab pegol; parenteral

28.6

85.4

117

M01CB01

ATC

sodium aurothiomalate; parenteral

9.4

83.9

179

198

M45

ICD-10 Finland

Ankylosing spondylitis

6.5

83.4

228

369

E000007

ATC

4.0

82.2

356

954

WZA10

NOMESCO Finland

Long statement of health and health related matters

8.9

81.8

180

210

M01AE02

ATC

naproxen; oral, rectal

1.9

80.7

2490

18408

L04AA11

ATC

[U] etanercept; parenteral

24.7

77.9

111

A02BC02

ATC

pantoprazole; systemic

1.8

74.4

2728

21090

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

71.1

577

2409

N02AX02

ATC

tramadol; systemic, rectal

1.8

70.9

1828

12500

NG1DA

NOMESCO Finland

X-ray of knees

6.9

70.3

183

277

291

Kela drug reimbursment

Tofacitinib

31.7

69.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

69.8

1760

11923

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.1

69.8

231

472

J01DB01

ATC

cefalexin; oral

2.0

69.3

3442

29150

L04AC16

ATC

guselkumab; systemic

347.8

68.8

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.4

67.8

259

615

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

12.9

67.6

122

R4120

NOMESCO Finland

Occupational therapy

3.3

67.1

371

1207

M01AH02

ATC

rofecoxib; oral

2.4

65.5

632

2888

D02AX

ATC

Other emollients and protectives

5.0

65.2

221

463

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

63.9

490

1974

ZX140

NOMESCO Finland

Intra articular

11.3

62.9

121

110

L04AA29

ATC

tofacitinib; oral

24.7

59.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

57.1

1962

14320

D07AA02

ATC

hydrocortisone; topical

2.3

56.9

619

2986

D07BC01

ATC

betamethasone and antiseptics; topical

2.3

56.5

575

2686

D07XB01

ATC

flumetasone, combinations; topical

13.9

54.5

N02BE01

ATC

paracetamol; systemic, rectal

1.9

54.1

3540

30986

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

9.0

54.1

117

133

J01FF01

ATC

clindamycin; systemic

1.8

53.7

1175

7433

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

+∞

53.2

3005

Kela drug reimbursment

Tofacitinib

23.0

53.2

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.7

52.5

125

166

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

11.0

51.5

100

L04AA17

ATC

[U] adalimumab; parenteral

18.2

49.3

H02AB04

ATC

methylprednisolone; systemic

2.1

49.2

662

3487

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

12.2

48.9

D05AC01

ATC

dithranol; topical

131.6

48.9

XX9XE

NOMESCO Finland

Other ultrasound examination

8.9

47.9

104

119

R4110

NOMESCO Finland

Physiotherapy

1.8

47.6

1092

6962

XQ848

NOMESCO Finland

Dermatological photography

4.9

46.6

157

327

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

46.0

558

2809

M07.1*L40.5

ICD-10 Finland

Arthritis mutilans

+∞

44.9

M073L

ICD-10 Finland

+∞

43.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

43.8

1184

7898

M07.2

ICD-10 Finland

Psoriatic spondylitis

432.0

43.3

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

23.3

43.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

43.0

341

1386

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

42.9

454

2145

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

14.3

42.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

42.4

319

1261

M01AB05

ATC

diclofenac; systemic, rectal

1.6

42.3

2763

23023

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

41.4

210

637

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

41.1

471

2305

J01DA01

ATC

[U] cefalexin; systemic

1.6

40.7

2507

20492

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

40.3

1527

11096

D05AX

ATC

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4240

29385

6.06

321.09

11.3

7.5

u/l

76.4

77.6

1.27

4163

27778

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1763

6328

3.88

307.65

1.3

u/ml

8.6

12.1

1.28

666

2541

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

626

961

7.37

307.65

1.7

1.4

—

(3021589) Normoblasts [#/volume] in Blood

3067

16884

3.40

307.65

16.1

9.1

e9/l

0.0

0.84

2783

13759

(3002030) Lymphocytes/100 leukocytes in Blood

3699

18356

5.98

307.65

13.8

5.9

29.6

28.2

13.45

3623

17119

(3019069) Monocytes/100 leukocytes in Blood

3684

17821

6.15

307.65

14.0

6.2

8.8

8.5

8.28

3604

16721

(3006315) Basophils [#/volume] in Blood

3969

19004

8.46

307.65

13.0

5.7

e9/l

0.0

7.73

3760

16416

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

914

1105

10.05

307.65

1.6

iu/ml

0.2

5.3

0.50

182

239

(3018010) Neutrophils/100 leukocytes in Blood

3674

18083

5.93

307.65

13.3

5.7

56.2

57.0

4.66

3599

16936

(3013707) Erythrocyte sedimentation rate by Westergren method

4231

28356

6.50

307.65

9.6

3.9

mm/h

12.2

11.4

3.53

4123

26400

(3013650) Neutrophils [#/volume] in Blood by Automated count

4076

21992

7.95

307.65

15.7

9.1

e9/l

3.9

4.1

4.79

3864

19192

(3001604) Monocytes [#/volume] in Blood

3958

18927

8.36

307.65

12.9

5.7

e9/l

0.6

3.44

3743

16364

(3002179) Metamyelocytes/100 leukocytes in Blood

1080

2822

4.68

307.65

4.8

3.9

0.3

0.6

3.33

169

619

(3019198) Lymphocytes [#/volume] in Blood

3972

19511

8.13

307.65

13.2

5.7

e9/l

2.0

1.9

0.79

3798

17230

(3022096) Basophils/100 leukocytes in Blood

3649

17161

6.24

307.65

13.6

5.9

0.8

0.7

16.51

3567

16018

(3021440) Promyelocytes/100 leukocytes in Blood

1143

2931

4.85

307.65

5.4

4.1

0.0

0.2

2.33

209

795

(3013115) Eosinophils [#/volume] in Blood

4003

19679

8.46

307.65

13.3

5.9

e9/l

0.2

0.24

3813

17302

(3006504) Eosinophils/100 leukocytes in Blood

3680

17706

6.18

307.65

13.5

5.9

2.9

0.47

3599

16517

(3025159) Blasts/100 leukocytes in Blood

1112

2755

4.99

307.65

5.4

4.1

0.0

0.2

0.76

184

666

(40760892) CBC W Ordered Manual Differential panel - Blood

2024

8566

3.41

307.65

8.1

4.3

—

(42870588) Differential panel, method unspecified - Blood

3060

12659

5.15

307.65

11.2

5.8

—

(3037522) Nuclear Ab [Titer] in Serum

1587

5259

4.06

307.65

1.4

1.3

titre

395.8

542.3

3.07

307

1075

(3017181) Myelocytes/100 leukocytes in Blood

1165

3091

4.70

307.65

5.3

4.1

0.6

1.0

4.00

215

869

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1709

6657

3.48

307.65

1.4

1.3

iu/ml

63.3

31.9

0.67

442

2131

(3000475) Leukocytes [#/volume] in Synovial fluid

539

869

6.89

307.65

2.0

1.6

e6/l

7380.6

13332.2

2.03

421

624

(3023420) DNA double strand Ab [Units/volume] in Serum

353

380

9.97

298.85

1.2

1.5

iu/ml

55.7

25.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3859

25624

3.98

293.98

6.5

4.1

—

(3021788) Differential panel - Synovial fluid

446

655

7.43

292.65

1.7

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

218

109

20.94

286.79

1.4

2.2

mg/l

8.6

9.0

0.25

165

(3008898) HLA-B27 [Presence]

633

1340

5.31

286.08

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

351

421

8.94

273.19

1.9

1.5

49.4

58.5

2.70

227

257

(3021601) Nitrite [Presence] in Urine by Test strip

3070

18310

2.99

269.42

6.7

4.6

estimate

0.0

0.80

799

3391

(3009261) Glucose [Presence] in Urine by Test strip

3090

18506

3.00

268.85

5.0

3.4

estimate

0.0

0.24

765

3272

(3035350) Ketones [Presence] in Urine by Test strip

3048

18259

2.95

262.41

4.9

3.4

estimate

0.0

1.08

753

3303

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

323

389

8.85

250.30

1.1

iu/ml

1.0

2.9

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

181

22.12

244.25

1.3

1.7

au/ml

259.9

77.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1989

10080

2.70

228.02

2.7

2.6

umol/l

3505.7

4166.7

0.36

1783

8864

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

284

335

8.96

223.45

1.9

1.4

39.6

31.8

1.84

174

204

(3021879) Hepatitis B virus core Ab [Presence] in Serum

884

2874

3.56

223.18

1.3

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

397

728

5.87

208.32

3.3

3.7

55.8

57.7

1.92

397

728

(3015736) pH of Urine

2429

14129

2.51

201.64

4.4

3.2

—

5.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1107

4374

3.01

200.22

1.3

1.6

—

(3044941) Cell count panel - Synovial fluid

340

600

6.04

185.34

1.6

1.4

—

(3018095) Leukocytes [#/volume] in Urine

2246

12983

2.41

183.76

4.0

3.6

e6/l

69.7

94.7

0.81

1559

9136

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1204

5363

2.68

170.41

1.4

1.6

—

(40758558) Short blood count panel - Blood

1786

9759

2.35

160.76

10.9

6.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2414

15398

2.18

144.32

2.5

2.2

nmol/l

76.4

77.0

0.45

2260

14015

(3034891) Synovial lining cells/100 cells in Synovial fluid

161

165

10.07

140.41

1.8

1.4

4.1

3.4

0.18

(3010144) Erythrocytes [#/volume] in Synovial fluid

210

340

6.42

124.33

1.7

1.3

e6/l

25306.1

69494.8

0.69

149

233

(3011397) Hemoglobin [Presence] in Urine by Test strip

1532

8585

2.17

122.66

4.5

3.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2174

14221

1.99

111.53

5.5

3.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1634

9759

2.04

107.49

5.6

3.8

estimate

0.0

2.17

788

3259

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4450

38813

4.46

106.89

22.6

13.3

mg/l

16.6

23.2

51.80

4032

30443

(3041096) Erythrocytes [Presence] in Urine by Automated

1655

9999

2.02

104.84

4.7

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

13.08

104.27

1.5

1.6

ug/l

9.2

8.4

0.76

100

(3002582) Erythrocytes [#/volume] in Urine

1777

11075

1.98

102.44

3.4

3.1

e6/l

42.9

100.3

2.63

1467

8451

(3030467) Casts [#/volume] in Urine by Automated count

1652

10177

1.97

97.35

3.3

3.0

e6/l

0.3

0.4

0.68

1343

7595

(46235355) HIV 1 and 2 tests - Meaningful Use set

1188

6508

2.11

97.08

1.5

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

1333

7660

2.04

95.43

2.8

2.6

e6/l

4.9

5.5

0.98

1204

6694

(3015171) Extractable nuclear Ab [Units/volume] in Serum

419

1477

3.02

88.59

1.2

u/ml

0.5

1.1

0.80

132

(36304419) Bacteria [Presence] in Urine

1577

9962

1.88

83.22

3.2

3.0

—

(3002385) Erythrocyte distribution width [Ratio]

3870

32453

2.15

81.85

26.8

16.1

13.9

13.6

27.63

3850

31773

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

275

788

3.65

81.24

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

354

1193

3.13

80.74

1.2

1.3

—

(3000494) Fungus identified in Specimen by Culture

865

4505

2.13

78.80

1.5

—

(3024263) Appearance of Synovial fluid

129

206

6.41

77.26

2.8

1.6

—

(3026782) Osmolality of Urine

1191

7058

1.92

75.09

3.1

2.7

mosm/kgh2o

562.8

545.8

1.75

1070

6023

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

116

8.52

75.07

2.5

2.6

au/ml

150.2

95.2

0.42

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

333

1161

3.01

71.43

1.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

127

7.78

69.64

2.6

3.0

mg/l

7.0

8.1

0.60

106

(40768443) Skin Pathology biopsy report

392

1522

2.72

68.81

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4173

36974

2.26

62.39

19.4

12.2

ml/min/173m2

86.0

83.0

16.73

3763

30625

(3042936) Bacteria identified in Isolate by Culture

911

5266

1.91

60.23

2.2

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2382

18245

1.63

56.05

6.0

6.9

mmol/l

1.2

0.02

2010

15509

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1008

6228

1.79

53.01

2.6

e6/l

1.0

1.2

0.61

656

3503

(3009871) Measles virus Ab [Titer] in Serum

123

6.77

52.14

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

557

2930

2.02

47.65

2.0

2.8

g/l

10.7

10.6

0.25

514

2682

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4482

41748

3.07

47.46

23.5

10.0

u/l

29.6

27.3

15.64

4445

40412

(3007853) Bacteria identified in Skin by Aerobe culture

748

4382

1.84

46.26

2.0

1.8

—

(3023368) Bacteria identified in Blood by Culture

1391

9672

1.63

46.13

4.5

4.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2469

19647

1.55

45.17

5.3

6.4

umol/l

10.6

11.3

1.76

2351

18689

(1761482) Bacteria [#/volume] in Urine by Culture

222

800

2.86

44.63

5.2

3.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2076

15946

1.55

44.28

4.4

5.0

g/l

35.7

35.8

0.43

1948

14904

(3007164) IgA [Mass/volume] in Serum or Plasma

1118

7425

1.67

44.15

1.5

g/l

2.6

2.4

2.32

707

4649

(3000330) Specific gravity of Urine by Test strip

373

1729

2.26

44.15

4.3

3.2

—

(3017732) Neutrophils [#/volume] in Blood

512

2713

2.00

42.69

3.6

2.8

e9/l

3.9

4.1

0.88

408

2185

(3018418) pH of Serum or Plasma

1505

10857

1.57

41.86

3.5

4.2

7.4

0.43

329

2066

(3048689) Calprotectin [Mass/mass] in Stool

756

4623

1.76

40.00

2.4

2.3

ug/g

139.8

137.5

0.05

618

3695

(3019150) Specific gravity of Urine by Refractometry

1161

7970

1.61

39.47

5.6

3.8

kg/l

1.0

1.46

174

1128

(3028026) IgM [Mass/volume] in Serum or Plasma

442

2283

2.03

39.47

1.6

1.9

g/l

1.1

1.3

2.63

402

2105

(3022948) Iron [Moles/volume] in Serum or Plasma

884

5736

1.67

37.39

2.5

umol/l

13.0

13.5

1.18

827

5344

(40761536) Microorganisms panel - Urine sediment

552

3137

1.86

37.07

4.4

3.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2883

24263

1.50

36.70

4.8

4.1

e6/l

1650.3

1630.9

0.01

329

(3045424) Erythrocytes [Presence] in Urine

181

651

2.85

36.51

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

127

374

3.46

35.91

3.0

2.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

773

4920

1.69

34.96

2.5

2.6

22.3

23.4

1.28

684

4248

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1252

8966

1.54

34.64

2.4

2.2

mg/l

3.1

2.9

2.15

1108

7697

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

249

1083

2.37

34.07

1.7

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

815

5302

1.65

33.77

2.5

g/l

2.4

2.3

1.08

759

4940

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

234

997

2.42

33.52

1.3

u/ml

13.4

7.8

0.49

165

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

246

1076

2.36

33.23

1.3

1.2

u/ml

5.9

46.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

514

2952

1.83

33.20

3.0

4.0

mmol/l

1.2

0.28

468

2586

(3013166) Neutrophils/100 leukocytes in Synovial fluid

125

5.34

33.18

1.6

1.2

47.1

53.4

0.60

106

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

198

786

2.59

32.97

1.3

1.2

u/ml

11.6

3.6

0.34

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2070

16561

1.45

32.52

5.3

6.2

mmol/l

1.2

0.05

1930

15101

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

229

986

2.39

32.05

1.3

1.2

u/ml

7.7

5.9

0.12

(3045414) Leukocytes [Presence] in Urine

338

1705

2.06

32.04

1.7

1.9

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

6.02

31.97

1.6

1.4

48.6

30.9

2.35

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

867

5807

1.61

31.73

2.9

2.8

e6/l

2.7

2.4

0.37

515

3103

(3007566) Smooth muscle Ab [Titer] in Serum

247

1107

2.30

31.53

1.2

1.3

titre

99.5

141.4

0.36

(3004809) Band form neutrophils/100 leukocytes in Blood

155

568

2.79

30.21

2.6

3.5

1.0

1.5

1.03

119

445

(3030981) Hyaline casts [#/volume] in Urine by Automated count

348

1823

1.98

29.65

2.5

2.7

e6/l

0.2

0.3

0.33

339

1774

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

982

6894

1.54

28.95

1.6

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1662

12996

1.43

28.35

3.5

3.3

u/l

33.1

35.3

0.73

1575

12380

(3039162) Centromere protein B Ab [Units/volume] in Serum

134

471

2.90

28.23

1.3

u/ml

99.8

47.5

—

(3034770) Mitochondria Ab [Titer] in Serum

236

1097

2.21

27.59

1.2

1.3

titre

522.0

1212.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1838

14734

1.41

26.84

2.1

1.9

pmol/l

92.7

96.5

2.96

1063

7664

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1144

8411

1.48

26.69

1.3

u/ml

1.6

1.8

0.24

311

2255

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

182

804

2.32

24.04

1.3

1.2

u/ml

46.6

48.8

0.05

(3013826) Glucose [Moles/volume] in Serum or Plasma

2566

21993

1.37

23.93

4.5

4.8

mmol/l

6.7

0.32

2420

20604

(40761535) Cells panel - Urine sediment

487

3019

1.68

23.76

5.0

3.3

—

(3032080) INR in Blood by Coagulation assay

1812

14724

1.38

23.42

8.9

8.4

inr

1.2

1.83

614

4280

(3027945) Reticulocytes/100 erythrocytes in Blood

591

3878

1.60

22.97

2.5

2.6

1.8

0.71

528

3471

(3026008) Bacteria identified in Urine by Culture

1323

10236

1.41

22.78

3.2

2.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1134

8538

1.43

22.76

1.7

1.8

mg/l

1.1

0.06

904

6493

(3021960) Folate [Moles/volume] in Serum or Plasma

1077

8055

1.44

22.35

1.7

1.5

nmol/l

20.7

20.4

0.21

947

6950

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1263

9751

1.41

21.84

2.9

3.0

ng/l

1274.8

1239.0

0.11

1076

8284

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

223

1112

2.06

21.76

1.6

g/l

0.2

0.85

213

1045

(3052851) Hemolysis interference index of Serum or Plasma

217

1074

2.07

21.61

2.4

3.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

540

3524

1.60

21.40

2.0

2.2

nmol/l

349.9

369.6

1.18

496

3242

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1433

11356

1.38

21.04

2.1

2.2

u/l

152.0

226.7

4.31

1349

10711

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

227

1162

2.00

20.61

1.6

g/l

1.3

1.2

2.38

219

1092

(3036670) Protein [Mass/volume] in Synovial fluid

4.77

20.07

1.2

g/l

36.4

38.1

0.43

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

595

4042

1.54

19.71

3.0

4.5

u/l

244.8

244.3

0.02

563

3840

(3019550) Sodium [Moles/volume] in Serum or Plasma

4214

39857

1.61

19.61

17.5

15.1

mmol/l

139.6

139.7

2.95

4128

38932

(3023520) Reticulocytes [#/volume] in Blood

442

2832

1.62

18.81

2.2

2.7

e9/l

73.5

70.7

0.74

330

2131

(3023103) Potassium [Moles/volume] in Serum or Plasma

4221

40000

1.60

18.75

17.7

15.2

mmol/l

3.9

4.0

4.30

4132

38998

(3019309) Folate [Moles/volume] in Red Blood Cells

849

6266

1.43

18.51

1.8

1.7

nmol/l

1149.6

1171.2

0.28

676

4826

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1931

16254

1.32

18.30

3.1

2.8

ug/l

139.2

129.7

0.80

1800

15171

(3036071) Salmonella sp Ab [Titer] in Serum

146

3.80

18.28

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1470

11909

1.34

18.11

2.6

u/l

54.0

58.4

4.17

1359

11052

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3840

35767

1.42

17.86

6.3

5.4

mmol/mol

39.9

39.5

1.49

3594

33397

(3020630) Protein [Mass/volume] in Serum or Plasma

444

2883

1.60

17.85

1.9

2.8

g/l

67.3

66.6

1.09

410

2651

(3013512) EKG study

1324

10582

1.35

17.78

4.3

3.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

380

2378

1.65

17.75

1.8

2.5

—

(3025941) Bacteria identified in Stool by Culture

350

2175

1.66

16.79

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

1576

1.76

16.56

1.5

1.7

g/l

1.6

0.23

227

1362

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

990

7631

1.38

16.55

1.8

1.6

pmol/l

83086841.1

33530297.6

0.60

810

6445

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

276

1619

1.75

16.37

2.8

0.7

1.03

267

1551

(3007461) Platelets [#/volume] in Blood

4499

43566

2.03

16.25

34.8

19.5

e9/l

258.4

252.3

8.07

4459

42556

(3015377) Calcium [Moles/volume] in Serum or Plasma

1503

12389

1.32

15.93

2.7

3.4

mmol/l

2.3

2.4

0.58

1346

10965

(3002032) Base excess in Venous blood by calculation

478

3238

1.53

15.90

3.9

mmol/l

2.3

2.0

1.12

393

2636

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3247

29637

1.32

15.82

4.2

3.9

pmol/l

14.7

0.07

2990

27201

(3035941) MCH [Entitic mass]

4499

43592

2.01

15.81

34.5

19.4

30.6

30.3

25.74

4482

43050

(3024731) MCV [Entitic volume]

4499

43593

2.01

15.79

34.6

19.4

92.2

90.9

68.38

4482

43054

(3026361) Erythrocytes [#/volume] in Blood

4499

43599

2.00

15.69

34.8

19.5

e12/l

4.5

14.59

4452

42488

(3035947) Staphylolysin Ab [Units/volume] in Serum

177

3.31

15.69

1.1

iu/ml

2.8

3.5

—

(3001729) Color of Synovial fluid

6.89

15.68

2.1

1.2

—

(40761511) CBC panel - Blood by Automated count

4267

40762

1.57

15.67

18.6

12.4

—

(3010813) Leukocytes [#/volume] in Blood

4499

43607

2.00

15.56

34.8

19.5

e9/l

6.9

6.6

13.69

4453

42486

(3000963) Hemoglobin [Mass/volume] in Blood

4499

43609

1.99

15.52

34.9

19.6

g/l

136.2

136.7

1.87

4481

43064

(3026389) Candida sp identified in Specimen by Organism specific culture

108

462

2.37

15.47

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

417

2761

1.56

15.37

2.3

2.4

au/ml

25.0

22.6

—

162

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1658

13901

1.30

15.35

3.9

3.4

ng/l

99.1

85.9

0.09

1120

9038

(3017354) Segmented neutrophils/100 leukocytes in Blood

339

2.60

15.21

2.9

3.6

59.4

56.7

0.48

221

(3021447) Carbon dioxide [Partial pressure] in Venous blood

474

3240

1.52

15.09

3.9

kpa

5.8

5.9

0.19

466

3143

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

395

2597

1.57

15.01

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

537

3776

1.48

14.88

3.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

397

2635

1.55

14.46

3.6

3.2

kpa

4.5

4.7

0.79

390

2551

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

302

2.64

14.37

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3780

35428

1.36

14.31

5.0

4.6

mu/l

1.8

2.1

2.59

3501

32736

(40768797) Stomach Pathology biopsy report

715

5337

1.40

14.29

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

306

2.61

14.01

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

302

2.61

13.84

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

380

2524

1.55

13.79

1.3

au/ml

55.1

48.9

—

114

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

303

2.60

13.76

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

306

2.58

13.49

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

306

2.58

13.49

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

237

1408

1.72

13.46

2.2

2.0

ug/l

1.9

2.4

0.39

210

1274

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

596

2.09

13.08

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

396

2.35

13.06

1.2

u/l

57.2

56.3

0.07

272

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

747

5696

1.37

13.04

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

501

3583

1.45

12.65

2.3

g/l

0.2

0.15

468

3356

(3020682) Albumin/Creatinine [Ratio] in Urine

1369

11437

1.28

12.39

4.1

4.0

mg/mmol

12.1

9.4

0.91

900

7303

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1367

1.69

12.04

1.7

2.4

g/l

4.2

3.8

2.64

153

1007

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1368

1.69

12.01

1.7

2.4

g/l

7.8

7.4

2.14

160

1055

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1368

1.69

12.01

1.7

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

127

647

1.99

11.82

1.3

1.6

g/l

0.6

0.8

0.86

493

(3022621) pH of Urine by Test strip

350

2364

1.52

11.75

3.3

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

784

6114

1.34

11.73

2.7

3.5

mmol/l

0.8

1.73

743

5750

(3022145) Colonoscopy Study observation

580

4327

1.39

11.49

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3812

36057

1.32

11.43

24.5

14.1

39.4

40.2

5.11

2685

27114

(3020961) Endomysium IgA Ab [Titer] in Serum

276

1788

1.58

11.18

1.1

titre

232.5

178.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

343

2.33

11.05

1.2

1.3

titre

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4078

39053

1.36

10.48

4.9

4.3

mmol/l

4.7

3.90

3837

36563

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

239

2.53

10.15

1.5

1.6

u/l

12.3

5.7

0.80

122

(3035611) Eosinophils/100 leukocytes in Synovial fluid

5.83

10.05

2.5

1.2

0.3

0.4

—

(3004616) Nuclear Ab [Presence] in Serum

471

2.06

9.97

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1264

1.64

9.96

1.7

2.4

g/l

10.8

10.3

0.67

176

1096

(3008757) Leukocyte morphology finding [Identifier] in Blood

379

2.18

9.93

2.1

4.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

205

1275

1.64

9.86

1.5

1.6

titre

576.4

353.5

0.31

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

231

2.53

9.83

1.2

1.6

u/l

5.5

7.1

0.97

194

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

127

697

1.85

9.53

1.1

1.2

—

282.9

—

(3009508) Creatinine [Moles/volume] in Urine

1368

11733

1.24

9.30

3.1

3.2

mmol/l

7.9

7.8

0.17

1135

9982

(3021901) Oxygen saturation in Capillary blood

116

624

1.88

9.28

3.0

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

173

1047

1.68

9.27

2.0

3.6

ratio

1.4

2.2

0.68

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

139

792

1.78

9.24

1.3

2.0

nmol/l

0.9

0.8

0.65

120

670

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1220

10341

1.24

9.24

1.7

1.6

mmol/l

1.5

1.4

4.09

1016

8717

(3033658) Prothrombin time (PT) actual/Normal

1161

9795

1.25

9.16

4.3

4.0

91.1

91.8

0.41

1133

9553

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3926

37530

1.30

9.14

4.4

3.8

mmol/l

1.4

1.3

10.13

3648

34765

(3034860) Kappa light chains.free [Mass/volume] in Serum

176

1075

1.66

9.11

2.0

3.7

mg/l

77.3

58.0

0.27

133

874

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

128

716

1.81

9.06

1.7

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

152

895

1.72

9.02

3.3

3.1

mmol/l

25.0

24.8

0.17

129

776

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

176

1078

1.66

9.02

2.0

3.7

mg/l

74.9

63.1

0.13

134

878

(3012516) Albumin [Mass/volume] in Urine

1277

10913

1.23

8.91

3.2

3.3

mg/l

391.3

379.2

0.03

819

6928

(3044889) 12 lead EKG panel

2942

27289

1.21

8.83

3.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2769

25536

1.21

8.83

3.0

2.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

199

1267

1.60

8.74

1.8

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1185

1.61

8.61

1.8

2.5

g/l

0.9

1.0

0.08

161

1045

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

177

2.61

8.41

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3940

37771

1.28

8.33

4.6

4.4

mmol/l

6.0

5.9

6.84

3630

34823

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1292

1.57

8.27

1.7

2.4

g/l

3.3

3.1

1.33

154

1031

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

248

1680

1.50

8.26

1.6

1.9

u/l

40.8

39.4

0.48

232

1502

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

572

4471

1.32

8.26

2.9

2.8

umol/l

9.8

7.9

0.60

488

3907

(3016650) Hepatitis A virus Ab [Presence] in Serum

119

676

1.78

8.04

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4035

38833

1.30

8.04

4.7

4.3

mmol/l

1.4

1.5

5.30

3766

36193

(4062490)

399

2.02

8.03

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

314

4324

0.71

8.02

1.3

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

508

3926

1.33

7.94

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

800

6565

1.26

7.91

2.6

3.0

mmol/l

2.4

0.09

705

5764

(1616796) Gas panel - Central venous blood

132

777

1.72

7.89

3.6

3.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

131

772

1.72

7.80

2.1

g/l

131.5

130.3

0.21

545

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

132

780

1.71

7.79

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

135

803

1.70

7.78

1.9

3.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

397

2.01

7.78

1.3

1.4

g/l

0.5

0.4

0.87

278

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

574

1.83

7.74

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

398

2.00

7.73

1.3

1.4

g/l

3.1

2.9

0.30

281

(3027135) IgG subclass 1 [Mass/volume] in Serum

398

2.00

7.73

1.3

1.4

g/l

6.6

6.8

0.23

279

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

216

1443

1.52

7.71

1.6

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

215

1437

1.52

7.66

4.0

5.8

1.5

1.7

1.43

202

1332

(3014051) Protein [Presence] in Urine by Test strip

140

847

1.67

7.58

2.1

2.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

193

2.45

7.56

1.1

u/l

79.4

85.5

0.16

153

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

193

2.45

7.56

1.1

u/l

29.4

25.4

0.09

147

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1054

1.60

7.43

1.7

2.3

g/l

0.0

1.65

151

979

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

791

1.69

7.42

2.5

5.9

iu/ml

172.2

592.5

—

116

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

639

5159

1.28

7.19

1.7

1.8

1.6

1.5

3.74

541

4573

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2880

26898

1.19

7.13

3.6

3.1

u/l

57.8

47.7

5.49

2698

25304

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

113

657

1.74

7.10

1.3

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4102

39672

1.29

7.06

5.2

4.7

mmol/l

2.8

2.77

3825

36935

(3028626) Oxygen [Partial pressure] in Capillary blood

127

764

1.68

7.05

3.1

2.8

kpa

8.0

8.2

0.69

119

699

(3002619) Bacteria identified in Specimen by Culture

3.50

6.98

1.5

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

576

4607

1.29

6.98

6.5

7.3

mmol/l

104.1

104.4

0.84

566

4501

(3005322) IgE [Units/volume] in Serum or Plasma

334

2474

1.38

6.89

1.3

u/ml

260.7

208.2

0.39

315

2298

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

307

2248

1.39

6.80

3.7

3.5

kpa

5.2

0.01

283

2095

(40767503) Oxygen content in Capillary blood by calculation

125

757

1.67

6.79

2.7

2.4

16.8

16.5

0.41

371

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

502

3959

1.30

6.77

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

261

1865

1.42

6.66

2.4

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

596

4815

1.27

6.66

5.1

6.3

mmol/l

1.0

1.02

576

4514

(3047007) Chlamydophila sp Ab [Presence] in Serum

568

1.76

6.55

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

208

1430

1.48

6.51

4.3

5.9

0.8

0.9

2.84

197

1327

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

178

1185

1.52

6.51

2.4

2.7

—

(3013637) Mi-2 Ab [Presence] in Serum

3.01

6.49

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.01

6.49

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.01

6.49

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.01

6.49

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

275

2.09

6.33

1.2

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

229

2.20

6.33

1.6

1.5

u/ml

20.7

21.7

0.05

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

152

984

1.56

6.32

1.8

2.4

g/l

0.0

0.00

138

913

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1080

1.54

6.32

1.8

2.3

g/l

37.5

37.8

0.21

141

955

(3044640) Blood type and Crossmatch panel - Blood

1351

11933

1.19

6.27

2.5

2.4

—

(3009343) pH of Capillary blood

299

2215

1.37

6.19

3.8

3.5

7.4

0.01

275

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

150

975

1.56

6.14

1.8

2.4

g/l

0.0

0.00

138

912

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1572

0.59

6.10

1.5

1.7

mg/l

3.9

0.00

1112

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

177

2.33

5.98

2.0

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

502

1.77

5.97

1.3

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

279

2059

1.38

5.92

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

477

1.78

5.80

1.0

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

286

2129

1.37

5.76

3.6

3.5

mmol/l

1.8

0.08

205

1602

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

583

1.70

5.75

1.2

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

1091

1.50

5.66

1.5

1.4

ug/g

278.1

288.3

0.27

623

(3048929) Epstein Barr virus Ab [Presence] in Serum

173

1182

1.48

5.63

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1947

17826

1.16

5.60

4.3

4.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

138

904

1.54

5.49

1.4

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

454

3636

1.28

5.44

2.9

2.4

u/l

38.3

51.8

0.50

400

3141

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

1005

1.51

5.39

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.62

5.25

1.1

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

551

4545

1.24

5.13

21.4

22.6

inr

1.2

1.3

0.23

677

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

134

887

1.53

5.11

1.4

1.7

—

(3017569) Oxygen content in Arterial blood

172

2.22

5.02

1.7

2.4

—

(3012501) Base excess in Blood by calculation

126

827

1.54

5.01

4.2

4.5

mmol/l

2.5

2.6

0.07

568

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

225

2.05

5.01

1.2

u/l

16.2

22.1

0.58

189

(36660697) Celiac disease serology panel - Serum

386

3065

1.28

4.97

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

268

2027

1.34

4.91

1.7

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

375

1.80

4.91

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

820

7077

1.19

4.82

3.7

3.5

ng/l

378.3

599.8

0.66

592

5304

(3009015) Lactate [Moles/volume] in Synovial fluid

3.79

4.81

1.1

1.3

mmol/l

3.6

5.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

342

2688

1.29

4.77

3.7

4.0

ng/l

80.9

89.5

1.19

288

2357

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

109

703

1.56

4.70

2.7

3.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

410

1.74

4.70

1.3

1.7

—

(3042631) Mycobacterium sp identified in Specimen

478

1.69

4.69

2.5

2.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

509

1.66

4.67

1.4

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

374

1.78

4.66

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

197

2673

0.73

4.65

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

120

794

1.52

4.63

1.7

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

179

1288

1.41

4.50

1.9

2.4

ug/l

330.6

707.7

1.04

162

1217

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

628

1.57

4.38

1.1

iu/ml

55.7

86.4

0.32

143

(3005011) Chlamydia sp Ab [Titer] in Serum

3.10

4.35

1.3

1.6

—

(3000991) Gas panel - Venous blood

377

3037

1.26

4.34

7.4

9.0

—

(40768804) Tissue Pathology biopsy report

1712

15748

1.14

4.25

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

470

3893

1.23

4.22

1.8

2.0

—

(3051101) Glucose [Moles/volume] in Cord blood

3.14

4.20

2.7

6.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

517

1.62

4.19

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

235

1.92

4.14

1.2

1.1

u/l

77.0

90.5

0.53

203

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

285

1.83

4.14

1.6

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

425

3493

1.24

4.11

1.8

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

641

1.54

4.03

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

659

5671

1.19

3.98

1.8

2.2

30.2

29.7

1.38

642

5513

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.54

3.96

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

156

1124

1.40

3.93

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

496

1.60

3.89

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

167

1221

1.38

3.87

2.7

3.2

g/l

0.3

0.24

506

(3014765) Yersinia sp identified in Stool by Organism specific culture

154

1115

1.39

3.79

1.2

1.1

—

(40768793) Breast Pathology biopsy report

861

0.58

3.77

1.4

1.3

—

(3010421) pH of Blood

138

982

1.42

3.75

4.0

4.4

7.4

0.49

124

817

(3011412) CD3 cells [#/volume] in Blood

364

1.68

3.67

1.7

2.5

e9/l

1.1

1.2

0.16

212

(3035320) C reactive protein [Mass/volume] in Body fluid

260

1.82

3.67

2.7

2.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

150

1088

1.39

3.66

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

152

1105

1.39

3.66

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

689

1.49

3.65

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

268

1.80

3.64

1.7

2.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1.87

3.63

1.3

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

1.87

3.58

1.1

—

(3037756) Immunofixation for Serum or Plasma

103

700

1.48

3.58

1.4

1.7

—

(44813793)

265

1.78

3.47

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

355

1.67

3.47

3.3

3.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

245

1930

1.28

3.44

8.5

10.1

mmol/l

24.7

24.3

1.22

227

1832

(1617658) Protocol used for examination of sentinel lymph nodes

303

0.33

3.40

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

313

1.70

3.35

1.2

titre

182.0

178.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

331

4013

0.81

3.33

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

378

3145

1.22

3.29

3.3

2.6

ml/min/173m2

67.7

68.1

0.06

160

1176

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

490

4180

1.19

3.28

6.6

7.8

kpa

5.2

5.1

2.30

475

3991

(3027801) Oxygen [Partial pressure] in Arterial blood

490

4181

1.19

3.27

6.6

7.8

kpa

12.4

12.6

0.37

472

3993

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

2.14

3.25

1.5

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

246

1957

1.27

3.21

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

317

1.68

3.21

1.7

2.3

48.4

42.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

116

826

1.41

3.20

2.9

3.0

umol/l

35.5

36.2

0.11

718

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

567

1.49

3.07

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

175

1340

1.32

3.07

1.9

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

196

1.84

3.01

1.3

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

382

3216

1.20

2.97

6.7

7.5

mmol/l

1.4

1.3

0.17

367

3093

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

621

1.46

2.96

1.7

2.9

u/ml

1202.8

1410.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

189

1471

1.30

2.96

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

279

1.69

2.95

1.6

2.2

11.7

13.1

0.49

122

(3041672) Baker's yeast Ab [Presence] in Serum

4.71

2.91

1.1

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.83

2.91

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

334

1.62

2.91

1.1

—

(40768800) Prostate Pathology biopsy report

749

0.61

2.87

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

171

1.88

2.85

1.1

miu/ml

1301.6

1468.6

0.47

171

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

252

1.71

2.84

1.1

1.2

—

(40768441) Liver Pathology biopsy report

298

1.65

2.83

1.2

1.5

—

(3016502) Oxygen saturation in Arterial blood

436

3733

1.19

2.83

7.2

8.3

95.5

95.8

0.73

424

3591

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

488

1.50

2.82

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

314

2611

1.22

2.79

1.2

iu/ml

107.6

144.4

0.98

119

982

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.76

2.75

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

195

1.80

2.75

1.3

1.6

—

(3003396) Base excess in Arterial blood by calculation

482

4172

1.17

2.75

6.8

7.9

mmol/l

1.2

1.0

0.33

397

3239

(3020650) Glucose [Presence] in Urine

104

2.12

2.74

1.3

1.4

—

(3022313) Gas panel - Capillary blood

204

1622

1.27

2.73

3.9

3.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

658

1.42

2.71

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

256

1.69

2.70

1.1

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

137

1034

1.33

2.70

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

310

1.62

2.69

1.1

—

(3000012) Reticulocyte production index

191

1.79

2.61

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.55

2.61

1.6

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

148

1.90

2.60

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

170

1.83

2.58

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

330

1.58

2.56

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

330

1.58

2.56

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

330

1.58

2.56

1.4

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

108

794

1.37

2.54

4.4

3.4

mg/l

22.3

26.0

0.48

480

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.47

2.48

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.47

2.48

1.0

—

(3023410) Appearance of Cerebral spinal fluid

397

1.52

2.48

1.4

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

144

1.88

2.45

2.0

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

366

1.54

2.45

1.4

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.24

2.43

1.8

2.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

109

810

1.35

2.41

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

131

1.91

2.40

1.1

1.3

—

(3000492) Spirometry study

454

3957

1.16

2.40

1.4

—

(3036603) Volume of Urine

251

1.64

2.36

1.8

1.5

2008.2

2000.9

0.01

(3039443) Prostate specific Ag panel - Serum or Plasma

879

0.68

2.36

1.5

1.6

—

(3028433) Virus identified in Specimen by Culture

132

1.90

2.35

1.2

—

(4211845)

183

1.75

2.35

7.0

3.0

—

(1761868) Lipid panel - Serum or Plasma

1598

15023

1.10

2.35

3.0

2.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

264

0.42

2.34

5.2

12.7

nmol/l

603.5

833.4

0.88

252

(3044927) Protein electrophoresis panel - Urine

332

1.54

2.29

1.4

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

163

1.78

2.26

1.3

2.5

umol/l

226.3

133.4

0.23

(3006462) Nitrate [Presence] in Urine

163

1.78

2.26

7.5

3.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

472

1.45

2.25

1.5

1.4

pmol/l

336.0

279.1

0.65

365

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

102

761

1.35

2.23

1.1

1.2

u/ml

315.3

277.4

0.50

474

(3016018) Differential panel - Cerebral spinal fluid

424

1.47

2.22

1.3

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

146

1149

1.28

2.18

1.2

1.3

miu/ml

174.0

211.9

0.57

535

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

134

1043

1.29

2.18

3.2

mg/l

1.5

0.23

115

975

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

738

1.35

2.18

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

738

1.35

2.18

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

611

0.64

2.15

4.1

5.4

umol/l

375.6

374.9

0.01

530

(21494814) CD8 cells/100 lymphocytes in Specimen

152

1.78

2.11

1.4

2.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

283

1.56

2.10

1.1

1.3

mmol/l

14.1

11.9

1.08

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

145

1.80

2.10

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

317

1.52

2.05

1.2

1.1

nmol/l

366.4

375.7

0.11

289

(4010399)

311

2667

1.18

2.05

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

2.64

2.01

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

1.79

2.00

1.2

1.6

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.82

2.00

1.2

1.1

—

3.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

224

1.61

1.99

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

468

1.42

1.99

1.3

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

201

1.65

1.98

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

299

2564

1.18

1.98

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

105

803

1.31

1.98

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

1.82

1.93

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.75

1.93

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.75

1.93

1.0

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.57

1.92

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

414

1.43

1.89

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

196

1.64

1.89

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

1.64

1.89

1.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

196

1.64

1.89

1.3

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

381

1.45

1.89

5.4

5.3

mmol/l

8.2

7.3

0.71

318

(3049717) Cytology report of Urine Cyto stain

163

1326

1.24

1.88

2.4

2.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

1.90

1.85

1.2

1.1

—

(3036489) Thrombin time

178

1466

1.22

1.84

1.8

2.1

22.9

21.5

0.78

153

1274

(3051651) Icteric interference index of Serum or Plasma

229

1.58

1.84

2.8

3.4

—

(3000285) Sodium [Moles/volume] in Blood

2.27

1.80

1.1

—

(3011985) Renin [Units/volume] in Plasma

503

1.38

1.80

1.5

mu/l

81.8

54.3

0.46

452

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

377

1.44

1.80

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.76

1.79

5.5

2.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

280

1.50

1.76

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.09

1.75

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.98

1.74

1.8

2.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

1.74

1.1

—

(3015183) Erythrocyte sedimentation rate

217

1.57

1.73

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

155

1268

1.23

1.73

1.7

1.6

mu/l

254.8

297.8

2.09

141

1152

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.85

1.71

1.2

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

137

1107

1.24

1.71

1.9

2.2

u/l

4276.7

4465.5

0.03

423

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

148

1.69

1.70

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

111

1.81

1.68

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

366

1.43

1.68

2.8

3.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

163

0.43

1.66

1.4

1.5

umol/l

32.7

29.6

—

156

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

119

1.77

1.66

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

196

1.59

1.65

1.3

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

373

3303

1.14

1.65

6.9

8.1

mmol/l

10.1

9.4

1.06

361

3165

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

204

1727

1.19

1.62

3.3

4.3

mmol/l

24.3

24.2

0.14

183

1557

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

213

1.55

1.62

1.8

2.4

u/ml

1012.1

1011.3

0.00

213

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

117

936

1.26

1.61

1.6

1.9

iu/l

3.1

5.0

2.78

347

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.61

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

268

2323

1.16

1.60

8.9

9.7

94.2

94.1

0.13

268

2316

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

254

1.50

1.60

1.9

2.6

e6/l

346.8

570.4

2.79

212

(3020491) Glucose [Moles/volume] in Blood

280

1.47

1.56

2.0

1.7

mmol/l

6.8

0.06

184

(3019420) Tryptase [Mass/volume] in Serum or Plasma

215

1.54

1.56

1.2

1.4

ug/l

7.7

8.2

0.12

191

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

397

1.39

1.56

1.2

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.93

1.54

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

184

1.58

1.54

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

153

1.64

1.53

1.2

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

153

1.64

1.53

1.2

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.16

1.50

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

154

1.63

1.49

1.2

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

131

1.68

1.49

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

116

940

1.24

1.46

1.8

1.9

pmol/l

199.8

203.5

0.15

106

887

(44816559) Phosphatidylethanol [Mass/volume] in Blood

770

1.27

1.45

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

429

1.36

1.44

1.2

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.92

1.43

1.1

1.3

—

(3004775) Volume in Urine collected for unspecified duration

294

1.43

2.0

2.3

731.9

623.2

0.69

202

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

343

3055

1.13

1.42

2.3

ug/l

5.4

8.1

3.62

294

2739

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

118

1.70

1.41

1.1

—

(3012441) Differential panel - Pleural fluid

329

1.40

1.4

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

134

1.64

1.38

1.9

2.2

24.8

30.2

1.09

124

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.89

1.38

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.20

1.37

2.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.94

1.36

1.0

1.1

—

17.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

213

1842

1.16

1.35

1.4

1.3

iu/l

30.0

30.7

0.11

187

1600

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

452

1.33

1.34

1.4

—

(1002224) Polysomnography panel

214

1854

1.16

1.33

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.74

1.30

1.1

u/ml

2.0

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.76

1.28

1.1

—

(3011288) Drugs identified in Urine by Screen method

115

947

1.22

1.28

1.8

3.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

385

3479

1.12

1.27

7.6

8.7

g/l

122.7

122.5

0.05

374

3343

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

500

1.30

1.27

6.2

6.7

mg/l

12.2

11.6

0.46

463

(44806420)

1.79

1.27

2.3

2.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.05

1.26

2.2

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

354

1.36

1.25

1.5

e6/l

20313.5

77199.2

1.58

211

(4146454)

381

1.34

1.23

2.8

2.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.91

1.22

2.7

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

237

1.44

1.22

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

460

1.31

1.22

1.4

1.5

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

u/ml

9.8

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

318

2852

1.12

1.21

3.0

2.8

ng/l

196.1

171.1

0.39

281

2590

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.72

1.21

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

134

1128

1.19

1.20

2.2

2.7

g/l

3.9

3.5

1.32

126

1069

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.31

1.18

1.3

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

126

1057

1.20

1.18

1.1

u/ml

2.0

6.4

1.69

136

(21494434) Karyotype in Bone marrow

315

1.37

1.18

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

419

1.32

1.17

1.0

1.1

—

85.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

1.16

0.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

660

1.25

1.15

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.64

1.15

1.1

1.3

96.6

89.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

158

1.52

1.14

1.3

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

134

1.57

1.14

2.0

2.3

9.5

9.4

0.01

122

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.14

0.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

156

0.51

1.13

3.9

2.4

nmol/l

152.0

150.7

—

133

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.75

1.12

1.6

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

284

1.38

1.12

1.6

2.0

u/field

2.3

2.0

0.12

125

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

726

1.23

1.11

1.3

1.4

u/ml

107.4

116.0

0.33

129

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.96

1.11

1.9

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

329

0.67

1.10

1.1

1.4

ug/l

2.9

3.8

0.33

276

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

255

0.63

1.07

7.4

6.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

373

1.32

1.07

1.8

2.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

244

1.40

1.07

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

822

1.21

1.06

1.4

—

(3023419) Bacteria identified in Sputum by Culture

463

1.28

1.04

1.8

2.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

280

1.36

1.03

1.2

1.3

u/ml

0.0

0.6

1.53

127

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.96

1.03

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

154

1.50

1.03

3.3

3.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

447

1.28

1.02

1.4

1.5

—

(3002256) Pathology report gross observation

538

5006

1.08

1.01

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

163

1.47

1.01

1.1

2.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

631

0.77

1.01

1.1

u/ml

0.3

1.9

—

148

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.00

1.00

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

1.46

0.99

2.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

1.46

0.99

2.2

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

189

1.43

0.98

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

566

1.24

0.98

1.1

u/ml

2.5

3.2

0.38

277

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.18

0.98

1.2

1.3

—

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.18

0.98

1.6

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

450

1.27

0.97

1.4

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.97

0.0

1.5

—

349.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

468

0.75

0.96

1.1

u/ml

0.7

0.3

—

102

(1001926) Buprenorphine [Presence] in Urine by Screen method

129

1110

1.17

0.95

1.5

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.78

0.94

1.1

—

6.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

778

0.81

0.93

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

477

0.75

0.93

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

160

1403

1.15

0.92

4.0

3.7

mmol/l

24.5

24.9

1.26

143

1313

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

227

2037

1.12

0.91

1.7

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

130

1124

1.16

0.91

2.3

2.5

190.9

187.0

0.19

122

1072

(3048879) Bone marrow aspiration report

102

1.57

0.90

1.3

1.9

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.07

0.89

1.0

1.2

—

(3019225) pH of Specimen

388

3584

1.09

0.89

3.6

4.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

1.53

0.87

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

298

1.31

0.87

1.1

—

(4034850)

147

1288

1.15

0.87

12.1

8.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.86

0.87

1.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

449

1.25

0.87

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

272

1.33

0.87

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

317

1.30

0.85

1.5

—

(3024928) Oxygen saturation in Venous blood

788

1.18

0.85

2.4

3.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

181

1612

1.13

0.84

1.6

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

142

1245

1.14

0.84

1.8

2.3

90.9

92.1

0.27

135

1160

(3023511) Choriogonadotropin [Units/volume] in Urine

551

1.22

0.83

1.4

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

178

0.62

0.82

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1281

12350

1.05

0.82

4.3

4.6

ug/l

2.2

2.5

0.44

1139

11186

(3003181) Sodium [Moles/volume] in Urine

616

1.20

0.82

1.3

1.4

mmol/l

64.7

64.1

0.04

499

(3023199) Leukocytes [#/volume] in Pleural fluid

399

1.26

0.82

1.5

e6/l

2781.6

2290.2

0.15

295

(3042517) Benzodiazepines panel - Urine

1.88

0.81

3.8

2.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.88

0.81

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

810

1.18

0.81

1.2

1.4

—

(3014271) Vancomycin [Susceptibility]

138

1.45

0.81

4.1

2.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

137

1202

1.14

0.81

2.8

3.3

u/ml

0.3

0.66

670

(40768446) Kidney Pathology biopsy report

164

0.61

0.80

1.5

1.6

—

(3004451) EKG impression Narrative

181

1.38

0.79

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

351

0.74

0.79

2.8

2.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

114

1.49

0.79

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.49

0.79

1.1

95.4

90.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

651

0.81

0.78

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

456

1.23

0.78

1.4

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.62

0.78

3.6

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

221

2003

1.11

0.78

8.5

10.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

507

0.79

0.78

1.1

u/ml

1.3

4.1

—

194

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

650

0.81

0.77

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.77

0.0

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

261

2387

1.10

0.77

2.7

3.4

pmol/l

4.5

0.02

226

2137

(3019977) pH of Arterial blood

208

1.35

0.77

4.2

3.4

7.4

0.19

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

649

0.81

0.76

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

157

1.40

0.76

1.2

6.4

mg/l

66.1

62.7

0.11

113

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.76

0.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

270

1.30

0.75

2.0

2.6

e6/l

574.1

706.5

0.42

115

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

648

0.82

0.75

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

538

0.80

0.75

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

414

3867

1.08

0.75

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

632

1.19

0.75

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

336

3113

1.09

0.75

2.1

2.2

nmol/l

13.1

13.4

0.30

288

2785

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

175

1.37

0.74

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

1.47

0.74

1.3

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

569

1.20

0.74

2.5

3.1

nmol/l

0.8

0.17

435

(3027923) C peptide [Moles/volume] in Serum or Plasma

210

1.34

0.73

1.5

1.4

nmol/l

1.7

1.2

1.31

159

(3020891) Body temperature

163

1459

1.12

0.73

5.0

4.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

103

894

1.16

0.73

2.0

2.4

ug/min

125.1

113.1

0.11

556

(3005033) Fetal Nuchal fold Thickness US

535

0.80

0.73

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

424

0.78

0.72

1.8

1.5

—

(3016750) Collection duration of Urine

220

1.32

0.71

1.8

2.2

min

527.3

489.8

0.92

165

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.92

0.70

4.8

3.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.92

0.70

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

102

888

1.15

0.70

1.3

1.4

e6/l

26.8

24.4

0.07

680

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

121

1369

0.88

0.69

1.8

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

102

889

1.15

0.69

1.4

1.5

e6/l

1121.6

1263.8

0.08

720

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

1.44

0.69

1.8

3.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

152

1.38

0.69

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

474

1.21

0.67

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

953

9896

0.95

0.66

3.8

3.9

21.7

21.5

0.10

401

4532

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

197

1.32

0.65

1.4

1.7

u/field

1.2

3.0

1.23

148

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

372

0.78

0.65

4.6

5.0

u/ml

35.7

73.8

0.97

104

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

277

1.27

0.65

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

745

1.16

0.65

1.8

1.7

—

(3017704) Immunofixation for Urine

189

1.32

0.64

1.2

1.6

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.72

0.64

1.0

1.3

—

40.2

—

(3000034) Microalbumin [Mass/volume] in Urine

368

1.23

0.63

2.8

3.1

mg/l

20.7

55.5

1.30

266

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

278

1.26

0.63

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

288

1.25

0.62

1.1

—

(3016879) Cocaine [Presence] in Urine

147

1325

1.11

0.61

1.4

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

246

2274

1.09

0.61

7.0

7.5

mmol/l

25.0

24.5

1.41

229

2116

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

637

1.16

0.61

1.3

1.2

u/ml

4.1

3.8

0.06

201

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

113

1003

1.13

0.61

1.2

1.3

mg/l

497.7

530.5

0.35

107

947

(44806071)

1.60

0.61

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

695

0.85

0.60

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.57

0.60

23.1

6.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.50

0.59

1.2

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

4.8

—

(3024316) Viscosity of Plasma

0.00

0.59

0.0

1.5

—

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

418

1.20

0.58

1.7

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

112

0.62

0.58

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

776

0.86

0.57

1.2

1.1

u/ml

0.5

1.3

2.03

300

(3000764) Benzodiazepines [Presence] in Urine

157

1428

1.10

0.57

1.4

2.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

159

1.32

0.55

1.0

1.1

ng/l

1613.2

458.4

—

(3028300) Cannabinoids [Presence] in Urine

158

1441

1.10

0.55

1.4

2.2

—

(3000060) B lymphocytes [#/volume] in Blood

1.42

0.54

1.7

2.2

e6/l

112.2

172.3

—

(3019060) Gas panel - Arterial blood

256

2388

1.08

0.53

4.6

5.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

349

0.80

0.52

1.6

1.5

g/l

1.0

0.13

349

(3027008) Opiates [Presence] in Urine

157

1436

1.10

0.52

1.4

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

567

5918

0.95

0.51

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

554

0.85

0.51

1.0

1.1

u/ml

4.0

3.1

0.15

204

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

136

0.66

0.51

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

885

1.12

0.51

1.2

1.3

mmol/l

3.6

3.8

0.99

828

(4035726)

319

3383

0.94

0.51

1.3

1.4

—

(3018572) Chloride [Moles/volume] in Blood

829

0.88

0.49

6.1

8.0

mmol/l

104.6

105.3

0.56

733

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.49

0.49

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.49

0.49

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.49

0.49

1.1

1.3

—

(3039000) Anion gap in Blood

828

0.88

0.49

6.1

8.0

mmol/l

11.1

11.3

0.20

732

(3003888) Timothy IgE Ab [Units/volume] in Serum

690

0.87

0.49

1.1

u/ml

4.0

5.1

0.15

348

(4133840)

110

1.36

0.48

1.5

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

382

1.18

0.47

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

245

1.23

0.46

1.2

1.1

ratio

1.1

1.0

0.41

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

418

0.84

0.45

1.2

—

(3027944) Amphetamines [Presence] in Urine

153

1410

1.09

0.45

1.4

2.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

0.67

0.45

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

0.67

0.45

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.40

0.45

1.0

—

(4281824)

406

0.84

0.44

1.2

—

(3042733) HLA Ab [Presence] in Serum

141

0.71

0.44

3.2

5.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

427

0.84

0.44

1.2

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

211

1.23

0.43

1.2

1.3

nmol/l

139.6

135.8

0.17

211

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

565

0.87

0.43

1.4

nmol/l

0.3

0.01

430

(3019897) Erythrocyte distribution width [Ratio] by Automated count

575

0.87

0.42

5.7

2.4

13.2

0.14

570

(3008401) Mugwort IgE Ab [Units/volume] in Serum

670

0.88

0.42

1.1

u/ml

1.4

1.1

0.08

276

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.66

0.42

1.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

122

1.31

0.42

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

574

0.87

0.42

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

110

1204

0.91

0.42

1.6

1.5

—

(44806118)

444

1.15

0.41

1.7

1.5

—

(44790047)

444

1.15

0.41

1.7

1.5

—

(44790048)

444

1.15

0.41

1.7

1.5

—

(44790049)

444

1.15

0.41

1.7

1.5

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

0.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

551

0.87

0.40

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.47

0.40

1.4

2.1

—

(3035880) pH of Pleural fluid

177

1.24

0.40

1.5

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

169

1.24

0.38

1.2

2.0

ug/l

347.4

22.4

0.47

154

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

444

4266

1.05

0.38

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

215

2281

0.94

0.38

1.8

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.34

0.38

1.0

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

112

0.71

0.37

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.35

0.37

1.8

2.4

u/field

0.2

0.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.37

1.2

1.1

umol/24h

1.8

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

701

7217

0.97

0.36

2.9

ug/l

0.6

0.7

8.65

442

4563

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

939

9163

1.03

0.36

2.5

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

114

1053

1.08

0.35

1.4

u/l

9.7

10.2

0.14

859

(3051593) INR in Capillary blood by Coagulation assay

153

1.24

0.35

9.1

10.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

266

0.83

0.35

1.5

—

(3012898) Urea [Moles/volume] in Urine

1.40

0.35

1.5

1.4

mmol/l

148.7

167.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

444

4605

0.96

0.34

7.2

6.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

211

0.80

0.34

3.5

6.3

u/ml

—

175.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

311

1.16

0.34

1.1

1.2

mg/l

45.4

40.5

0.18

256

(3028707) Methadone [Presence] in Urine by Screen method

626

1.10

0.32

1.6

3.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

239

1.17

0.31

2.3

1.8

—

(3022689) Creatine [Moles/volume] in Urine

120

1.25

0.30

1.1

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

142

1336

1.06

0.29

3.7

3.6

u/ml

1045.7

3943.7

0.71

121

1144

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

0.73

0.28

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

121

0.74

0.27

1.4

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.23

0.27

1.4

1.8

—

(40758292) HTLV I+II Ab panel - Serum

1.19

0.26

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

384

0.88

0.26

1.4

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.26

0.26

1.6

1.3

—

(4198724)

171

0.82

0.26

1.6

2.8

—

(3024869) Neuronal Ab [Presence] in Serum

0.69

0.26

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

351

0.88

0.25

1.2

1.4

pmol/l

65.0

153.2

0.51

109

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.20

0.25

2.8

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.25

0.24

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

223

0.85

0.24

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.71

0.24

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

115

1.22

0.23

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.28

0.23

1.8

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.22

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

135

0.81

0.22

2.1

2.5

umol/l

35.8

28.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.19

0.21

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.2

—

250.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

6.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

109

1033

1.06

0.20

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

439

0.91

0.20

2.3

2.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.20

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

108

1.20

0.20

2.2

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

114

0.79

0.20

9.3

3.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

114

0.79

0.20

9.3

3.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

269

1.12

0.19

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

146

1.16

0.19

1.5

—

(3045142) Bone marrow Pathology biopsy report

426

0.91

0.18

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

347

1.10

0.18

1.6

—

(4024509)

332

0.90

0.18

1.7

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.21

0.18

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.21

0.18

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

166

1.15

0.18

1.7

1.8

—

(4015189)

1.21

0.17

3.2

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

0.84

0.17

1.2

1.1

—

(3003338) MCHC [Mass/volume]

3388

33741

1.02

0.17

30.2

16.8

g/l

331.8

332.8

9.35

3375

33520

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.13

0.17

1.6

1.7

ng/l

170.1

120.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

611

1.06

0.17

1.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

777

1.06

0.17

2.7

3.6

u/ml

314.4

647.1

0.44

717

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.71

0.16

3.8

3.3

u/l

23412.0

2492.4

—

(40765096) Chromosome analysis panel by Banding

120

1.17

0.16

1.4

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

448

4568

0.98

0.16

4.5

4.4

31.3

32.0

0.68

338

3168

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

193

0.88

0.15

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.76

0.15

1.5

2.2

umol/l

14.4

17.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

387

3792

1.02

0.15

3.2

4.2

ug/l

30.5

23.7

0.14

318

3065

(3002523) Influenza virus A Ag [Presence] in Specimen

676

0.95

0.14

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

676

0.95

0.14

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

227

1.10

0.14

2.7

2.8

45.3

40.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

981

0.96

0.14

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

124

1284

0.96

0.13

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

354

1.07

0.13

2.1

2.0

umol/l

6.9

0.00

244

(3047189) Immunofixation for 24 hour Urine

180

1.11

0.13

1.9

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

374

1.07

0.13

1.1

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

200

1.10

0.12

2.0

2.5

—

24.6

—

(3011648) Oxygen content in Venous blood

307

1.08

0.12

1.8

2.5

10.1

11.3

0.97

307

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

200

1952

1.03

0.12

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.16

0.11

7.6

7.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

172

1.11

0.11

3.5

2.7

—

(4027681)

240

1.08

0.11

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

681

1.04

0.11

1.4

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

623

1.04

0.10

1.3

1.2

u/ml

5.7

4.7

0.21

266

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

464

0.95

0.10

2.3

3.3

nmol/l

125.6

5.6

0.49

452

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

135

0.89

0.09

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

203

1.08

0.09

2.1

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

330

0.94

0.09

1.5

1.6

promille

1.1

1.3

0.27

255

(3019832) Treponema pallidum Ab [Presence] in Serum

307

3022

1.02

0.09

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

233

1.07

0.09

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.11

0.09

1.2

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

282

1.06

0.08

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.07

0.08

2.5

2.4

pmol/l

54.9

78.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

136

1.10

0.08

1.9

1.5

pmol/l

14.0

15.6

0.81

115

(3008295) Osmolality of Serum or Plasma

400

1.05

0.08

1.5

1.4

mosm/kgh2o

282.6

280.2

0.27

314

(3043409) Potassium [Moles/volume] in Arterial blood

107

1099

0.97

0.08

4.9

4.3

mmol/l

3.9

0.19

101

1030

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

491

0.96

0.08

2.0

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.79

0.08

3.2

2.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.09

0.08

1.6

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.06

0.08

7.1

7.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.84

0.07

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.83

0.07

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1341

1.02

0.07

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

225

0.93

0.07

1.0

1.1

u/l

0.9

1.1

—

116

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

286

0.94

0.07

2.4

1.7

—

(3025130) Human papilloma virus identified in Specimen

481

1.04

0.07

1.6

1.8

—

(40757373) Influenza virus identified in Isolate

0.87

0.07

1.9

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.06

0.07

7.8

8.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

255

0.94

0.07

1.1

nmol/l

20.0

5.2

—

(3044007) Cell count panel - Peritoneal fluid

118

1.10

0.07

1.8

2.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.87

0.06

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.86

0.06

1.9

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

132

0.91

0.06

1.8

2.1

e6/l

313.4

19760.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

263

0.95

0.05

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

198

1.06

0.05

2.1

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

110

1.09

0.05

1.0

1.1

—

3.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

504

0.97

0.04

1.2

1.3

mmol/l

9.2

7.3

2.27

374

(3034426) Prothrombin time (PT)

150

1.07

0.04

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1069

10652

1.00

0.04

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

568

1.02

0.03

1.2

1.4

u/l

24.1

29.1

0.74

463

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

211

1.04

0.03

1.4

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

271

1.03

0.02

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

153

1.05

0.01

2.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

153

1.05

0.01

2.0

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

1.05

0.01

2.7

2.4

—

(3024932) HLA-DR beta [Type]

136

0.96

0.00

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

216

0.97

0.00

1.2

—

(4306422)

634

1.01

0.00

1.2

—

(3024471) HLA-A [Type]

138

1.01

0.00

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

178

1.01

0.00

1.3

1.6

mmol/l

9.4

8.0

—

105

(3014599) Egg white IgE Ab [Units/volume] in Serum

228

1.01

0.00

1.1

1.0

u/ml

9.0

0.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

232

0.99

0.00

1.1

1.0

u/ml

26.8

3.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

435

1.01

0.00

2.2

mg/l

30.9

22.0

0.36

118

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

106

1.04

0.00

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.03

0.00

1.2

1.1

—

296.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

473

0.99

0.00

1.6

1.7

—

(4094501)

114

1144

1.00

0.00

1.1

—

(3033799) Differential panel - Peritoneal fluid

121

0.99

0.00

2.8

2.1

—

(3047181) Lactate [Moles/volume] in Blood

116

1163

1.00

0.00

4.7

6.9

mmol/l

1.3

0.21

103

1013

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

105.5

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.88

0.00

1.0

1.8

pmol/l

27.1

37.4

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.2

—

2.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.99

0.00

1.1

1.3

—

131.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.02

0.00

1.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.95

0.00

1.3

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.97

0.00

5.2

5.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.3

—

124.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.7

—

0.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.91

0.00

1.0

2.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(4268621)

430

1.00

0.00

2.5

2.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

576.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.00

0.00

1.4

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1150.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

3210.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_PSORI_ARTHRO – Arthropathic psoriasis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Arthropathic psoriasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Arthropathic psoriasis (L12_PSORI_ARTHRO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints